Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Capital Expenditures (2022 - 2025)

Historic Capital Expenditures for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $49000.0.

  • Envoy Medical's Capital Expenditures fell 9495.88% to $49000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$478000.0, marking a year-over-year decrease of 13114.01%. This contributed to the annual value of $980000.0 for FY2024, which is 54052.29% up from last year.
  • Envoy Medical's Capital Expenditures amounted to $49000.0 in Q3 2025, which was down 9495.88% from $1000.0 recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Capital Expenditures ranged from a high of $972000.0 in Q3 2024 and a low of -$534000.0 during Q4 2024
  • Moreover, its 4-year median value for Capital Expenditures was $45000.0 (2022), whereas its average is $102500.0.
  • The largest annual percentage gain for Envoy Medical's Capital Expenditures in the last 5 years was 383636.36% (2024), contrasted with its biggest fall of 264285.71% (2024).
  • Over the past 4 years, Envoy Medical's Capital Expenditures (Quarter) stood at $41000.0 in 2022, then tumbled by 48.78% to $21000.0 in 2023, then crashed by 2642.86% to -$534000.0 in 2024, then surged by 109.18% to $49000.0 in 2025.
  • Its Capital Expenditures was $49000.0 in Q3 2025, compared to $1000.0 in Q2 2025 and $6000.0 in Q1 2025.